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In the last few years several new 
vaccines have been added to 
the list of recommended immu-
nizations for infants, children 
and adolescents. As a result it 
has been necessary to update 
the recommended schedule. 
The revised schedules are 
provided here (see pages 5-6) 
for your convenience, as well 
as the rationale for the recently 
added vaccines.
The Advisory Committee on 
Immunization Practices (ACIP) 
periodically reviews the rec-
ommended immunization 
schedule for persons aged 
0-18 years to ensure that 
the schedule is current with 
changes in vaccine formula-
tions and reflects revised 
recommendations for the use 
of licensed vaccines, including 
those newly licensed. 
Changes in the new, 2007 
childhood and adolescent im-
munization schedule include:
● Rotavirus vaccine.  The 
recommended administra-
tion of the new rotavirus 
vaccine, RotaTeq, is a 3-
dose schedule at ages 2, 
4, and 6 months.  Children 
should be given the first 
dose between the ages of 
6-12 weeks. Subsequent 
doses should be adminis-
tered at 4-10 week inter-
vals. 
● Varicella vaccine. Varicel-
la vaccine recommenda-
tions have been updated. 
Children should receive 
the first dose at age 12-15 
months. A newly recom-
mended second dose 
should be administered at 
age 4-6 years.
An Update: 2007 
Recommended Immunization Schedules 
Birth to Age 18
Ellen Link, MD, Department of Pediatrics, Iowa Children’s Hospital
Teresa Thornton, RNC, Iowa Department of Public Health
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● Human papillomavirus 
vaccine (HPV). The new 
human papillomavirus vac-
cine is recommended in a 
3-dose schedule for girls. 
The first dose of the series 
may be administered to girls 
as young as 9 years old, with 
routine vaccination recom-
mended for girls between 
the ages of 11-12 years. 
The second and third doses 
should be given 2 months 
and 6 months after the first. 
Catch-up vaccination is rec-
ommended for females age 
13-26 years who have not 
been vaccinated previously 
or who have not completed 
the full series. (See also 
HPV, page 3.)
Two schedules. This year, the 
schedule of recommended im-
munizations has been broken 
into two schedules:
● Immunizations for children 
from birth through 6 years
● Immunizations for children 
from 7-18 years
A  schedule for catch-up immu-
nizations for children from age 
4 months through 18 years is 
also available. This schedule 
can be used with children who 
are beginning immunizations 
late or are more than a month 
behind on immunization.
These schedules have been 
approved by the Advisory 
Committee on Immunization 
Practices, the American Acad-
emy of Pediatrics, and the 
American Academy of Family 
Physicians.
Vaccine updates
Hepatitis A. All children should 
receive hepatitis A vaccine, 
beginning at 1-2 years of age, 
as part of the routine child-
hood schedule (MMWR May 
19, 2006).
Influenza. Routine vaccination 
for influenza is now recom-
mended for all children age 6 
months through 5 years.  Vacci-
nation is also recommended for 
household contacts and out-of-
home caregivers of all children 
through 5 years of age.
Pertussis. In the spring of 
2005, for the first time in his-
tory, vaccines became avail-
able to protect teenagers 
and adults against whooping 
cough. Two new vaccines, for 
tetanus, diphtheria and pertus-
sis (Tdap), were licensed and 
recommended. Adolescents 
11-18  years old should receive 
a single dose of Tdap instead 
of Td, preferably at 11-12 years 
of age. All adults through 64 
years of age, and especially 
adults who anticipate close 
contact with infants less than 
a year old – such as parents, 
child care providers, and health 
care professionals – should 
be immunized with a single 
booster dose of Tdap.
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tion System, helps Iowa 
health care providers and 
families by consolidating 
immunization information 
into one reliable source. 
IRIS saves money by 
ensuring that children 
get only the vaccines 
they need. In addition, 
IRIS improves office ef-
ficiency by reducing the 
time needed to gather 
and review immunization 
records.
Learn more about IRIS
Visit:  http://www.idph.
state.ia.us/adper/iris.asp
Call:   IRIS Help Desk, 
800-374-3958






Human papillomavirus (HPV) 
is the most common sexu-
ally transmitted infection in 
the United States. More than 
100 types of HPV are known, 
and about 40 of these infect 
the human genital tract. HPV 
infects the skin, genital area, 
and lining of the cervix. Fifty to 
75% of sexually active adults 
acquire at least one type of 
HPV during their lifetime. 
Although most of these infec-
tions are asymptomatic and 
clear spontaneously, the FDA 
estimated that in 2006 more 
than 9,700 women in the U.S. 
would be diagnosed with cervi-
cal cancer, and 3,700 women 
would die of this disease. 
In 2006 the FDA approved 
the HPV vaccine Gardasil, 
and the Advisory Committee 
on Immunization Practices 
recommended the vaccine be 
incorporated into the routine 
schedule of childhood immu-
nizations. A quadrivalent HPV 
vaccine, Gardasil is 90-100% 
effective against:
● HPV types 16 and 18, 
which cause about 70% of 
cervical cancers
● HPV types 6 and 11, which 
cause about 90% of genital 
warts
Vaccination is recommended 
for girls between the ages of 
11-12, and licensed for use in 
(continued from page 2)




























Vaccines and the diseases 
they prevent, http://www.cdc.
gov/nip/menus/diseases.htm
females between the ages of 9 
and 26. Immunization is most 
effective when given before a 
girl becomes sexually active, 
as it then provides protection 
against all four HPV types. 
Although the vaccine has no 
therapeutic affect against ex-
isting disease, sexually active 
young women can also ben-
efit, as they will be protected 
against any of the four types of 
HPV which they have not yet 
contracted. 
Routine screening using the 
Pap test is still vital, for Gardasil 
protects against only four of the 
more than 100 types of HPV, 
and does not safeguard young 
women who have already con-
tracted HPV. 




In February 2005 the Center 
for Disease Control Advisory 
Committee on Immuniza-
tion Practices (ACIP) recom-
mended routine vaccination 
of adolescents 11-12 years 
of age with a meningococcal 
conjugate vaccine (MCV4), 
Menactra. 
This vaccine protects against 
several strains of Neisseria 
meningitides, which causes 
bacterial meningitis -- a sud-
den and serious disease that 
can have a very rapid course. 
Death occurs in 10-14% of all 
cases; 11-19% will suffer seri-
ous sequelae that can include 
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deafness, neurologic deficit, or 
limb loss.  
Routine vaccination with Menac-
tra is now recommended for:
● Children age 11-12 years of 
age
● Adolescents entering high 
school 
● College freshmen, especially 
those living in dormitories
Menactra vaccination continues 
to be recommended for other 
populations at increased risk 
for meningococcal disease, 
including people who:
● Are entering the military 
● Are traveling or living in coun-
tries where N. meningititides 
is hyperendemic or epidemic
● Have terminal compliment 
deficiencies
● Have functional or anatomic 
asplenia
● Have HIV infection 
In 2005, the FDA and CDC 
issued an alert about Guil-
lain-Barre Syndrome (GBS) 
occurring among recipients of 
Menactra. GBS is a rare but 
serious neurologic disorder 
involving inflammatory demy-
elination of peripheral nerves. 
At this point, CDC is unable to 
determine whether Menactra 
increases the risk of GBS in 
persons who receive the vac-
cine, for its background rate is 
not precisely known.  
Because the risk for serious 
meningococcal disease is sig-
nificant, the CDC continues to 
recommend Menactra vaccina-
tion for the populations above. 
Health care providers should 
talk with adolescents and their 
caregivers about this concern; 
providers should use the CDC’s 
“Meningococcal Vaccine Informa-




While this investigation is ongo-
ing, people with a history of GBS 
who are not in a high risk group 
for meningococcal disease 




Providers should report vac-
cine-related adverse effects, 
including GBS or intussus-
ception, by contacting: 
VAERS (Vaccine Adverse 
Events Reporting System) 
http://www.vaers.hhs.gov 
1-800-822-7967
Rotavirus      
Vaccine
Rotavirus is the leading cause 
of severe gastroenteritis in 
infants and toddlers. The AAP 
reports that nearly all children in 
the US will have been infected 
by rotavirus by the time they are 
5 years old. Severe rotavirus 
gastroenteritis is primarily found 
in children age 3 months to 3 
years. The CDC reports that 
each year in the US, rotavirus 
is responsible for about:
● 410,000 physician visits




RotaTeq. RotaTeq is a new 
rotavirus vaccine, licensed 
by the FDA for use in infants. 
Studies indicate that adminis-
tering three doses of RotaTeq 
vaccine to infants 6- 32 weeks 
old prevents:
● 74% of all cases of rotavirus
● 98% of the most serious 
rotavirus infections 
The American Academy of Pe-
diatrics recommends routine 
immunization, using 3 doses of 
RotaTeq given orally at 2, 4, and 
6 months of age.  Infants must 
receive the first dose at between 
6 and 12 weeks of age. Doses 
are given at 4-10 week intervals, 
and all three doses should be 
given before the infant is 32 
weeks old.
Intussusception. In February 
2007 the FDA notified health 
(continues on page 7)
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Coming Your Way…
Public-Private Partnerships for Early 
Childhood Healthy Mental Development
Teresa Thornton, R.N.C., Iowa Department of Public Health
Sonni Vierling, Iowa Department of Public Health
care providers and consumers 
about reports of intussuscep-
tion following administration 
of RotaTeq. It is not known 
whether these incidents are 
vaccine-related; CDC un-
published data show that the 
number of cases reported 
to date does not exceed the 
number expected based on 
background rates. 
The AAP continues to recom-
mend the routine use of Ro-
taTeq. Providers should talk 
with parents about risks and 
benefits, and ask them to con-
tact the provider immediately 
if their child shows signs of 
intussusception. Symptoms 
of intussusception, which can 
appear several weeks after 
vaccination with RotaTeq, 
are:
● Blood in stool





For more information, visit 




(continued from page 4)
Have you ever:
● Made a referral and then 
wondered, “Did the family 
make the call? 
● Worked with a family who 
continually misses well-
child visits due to family 
stress?
● Not asked probing ques-
tions about parental 
depression because you 
weren’t sure whether 
community resources 
existed for referral? 
If these questions are familiar, 
public-private partnerships 
can help. They offer a stream-
lined process, from identifica-
tion of developmental and 
social-emotional concerns to 
coordination of referrals and 
follow-up. 
Iowa’s Assuring Better Child 
Development (ABCD II) proj-
ect has made real progress 
in infusing healthy mental 
development principles and 
practice into Iowa’s Med-
icaid EPSDT system. The 
last issue of this newsletter 
highlighted the screening 
standards resulting from 
this three-year project (www.
iowaepsdt.org/Screening 
Resources/Standards.htm); 
another critical component 
is a public-private system 





ship promotes healthy mental 
development by enhancing 
the referral process and link-
ing with effective services for 
children at risk. Medical pro-
viders who participated in the 
ABCD II project acknowledge 
that the expertise of local pub-
lic health agencies is often the 
key to effective referrals for 
families and children. 
The fall ‘07 EPSDT Care for 
Kids Newsletter will feature 
creative strategies that pub-
lic-private providers have 
developed to serve families 
better through more effective 
referral and follow-up.
PLEASE NOTE new email ad-
dress: To contact Kris Tiernan 
for information about opportu-
nities available to your practice 
for ABCD II training and techni-
cal assistance, email kristin-
tiernan@uiowa.edu.
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Children’s Hospital of Iowa
Center for Disabilities and Development
University Center for Excellence on Disabilities
100 Hawkins Drive
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knowledgment with reprinted material: Reprinted by permission of the Iowa 
EPSDT Care for Kids Newsletter.
The EPSDT Care for Kids Newsletter is 
published three times a year, in print and 
online, as a joint effort of the Iowa Preven-
tion of Disabilities Policy Council, the Iowa 
Department of Human Services, the Iowa 
Department of Public Health, and the Center 
for Disabilities and Development, which is 
nationally designated as Iowa’s University 
Center for Excellence on Disabilities. The 
goal of this newsletter is to inform Iowa 
health care professionals about the EPSDT 
Care for Kids program, to encourage them 
to make use of this important resource, 
and to provide them with information about 
a wide range of developments in the field 
of health care. 
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the newsletter should be addressed to:
Claibourne I. Dungy, MD, MPH
or Ellen Link, MD
Family Care Center – Pediatrics
University of Iowa Hospitals and Clinics
200 Hawkins Drive   01212 - PFP
Iowa City, IA 52242-1083
If you have questions about billing
related to EPSDT Care for Kids services, please call 
Provider Services:  1- 800-338-7909
If you have questions about clinical issues 
and EPSDT Care for Kids services, please call 
1 - 800-383-3826
